Found: 5
Select item for more details and to access through your institution.
The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.
- Published in:
- Nature Communications, 2015, v. 6, n. 3, p. 6537, doi. 10.1038/ncomms7537
- By:
- Publication type:
- Article
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-88
- By:
- Publication type:
- Article
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis.
- Published in:
- Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00496
- By:
- Publication type:
- Article
Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 5, p. 1432, doi. 10.3390/jcm11051432
- By:
- Publication type:
- Article